BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

184 related articles for article (PubMed ID: 25093816)

  • 21. Adenoviral gene transfer with soluble vascular endothelial growth factor receptors impairs angiogenesis and perfusion in a murine model of hindlimb ischemia.
    Jacobi J; Tam BY; Wu G; Hoffman J; Cooke JP; Kuo CJ
    Circulation; 2004 Oct; 110(16):2424-9. PubMed ID: 15477417
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Impaired cross-activation of β3 integrin and VEGFR-2 on endothelial progenitor cells with aging decreases angiogenesis in response to hypoxia.
    Di Q; Cheng Z; Kim W; Liu Z; Song H; Li X; Nan Y; Wang C; Cheng X
    Int J Cardiol; 2013 Oct; 168(3):2167-76. PubMed ID: 23452889
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Naoxintong restores collateral blood flow in a murine model of hindlimb ischemia through PPARδ-dependent mechanism.
    Chen L; Zhang L; Fang Z; Li C; Yang Y; You X; Song M; Coffie J; Zhang L; Gao X; Wang H
    J Ethnopharmacol; 2018 Dec; 227():121-130. PubMed ID: 30170078
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Far infra-red therapy promotes ischemia-induced angiogenesis in diabetic mice and restores high glucose-suppressed endothelial progenitor cell functions.
    Huang PH; Chen JW; Lin CP; Chen YH; Wang CH; Leu HB; Lin SJ
    Cardiovasc Diabetol; 2012 Aug; 11():99. PubMed ID: 22894755
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Androgen receptor promotes sex-independent angiogenesis in response to ischemia and is required for activation of vascular endothelial growth factor receptor signaling.
    Yoshida S; Aihara K; Ikeda Y; Sumitomo-Ueda Y; Uemoto R; Ishikawa K; Ise T; Yagi S; Iwase T; Mouri Y; Sakari M; Matsumoto T; Takeyama K; Akaike M; Matsumoto M; Sata M; Walsh K; Kato S; Matsumoto T
    Circulation; 2013 Jul; 128(1):60-71. PubMed ID: 23723256
    [TBL] [Abstract][Full Text] [Related]  

  • 26. P2Y2 nucleotide receptor mediates arteriogenesis in a murine model of hind limb ischemia.
    McEnaney RM; Shukla A; Madigan MC; Sachdev U; Tzeng E
    J Vasc Surg; 2016 Jan; 63(1):216-25. PubMed ID: 25088742
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Controlled delivery of vascular endothelial growth factor promotes neovascularization and maintains limb function in a rabbit model of ischemia.
    Hopkins SP; Bulgrin JP; Sims RL; Bowman B; Donovan DL; Schmidt SP
    J Vasc Surg; 1998 May; 27(5):886-94; discussion 895. PubMed ID: 9620141
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Interleukin-19 increases angiogenesis in ischemic hind limbs by direct effects on both endothelial cells and macrophage polarization.
    Richards J; Gabunia K; Kelemen SE; Kako F; Choi ET; Autieri MV
    J Mol Cell Cardiol; 2015 Feb; 79():21-31. PubMed ID: 25450612
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Perlecan heparan sulfate proteoglycan is a critical determinant of angiogenesis in response to mouse hind-limb ischemia.
    Qiang B; Lim SY; Lekas M; Kuliszewski MA; Wolff R; Osherov AB; Rudenko D; Leong-Poi H; Noyan H; Husain M; Tran K; Tryggvason K; Hedin U; Tran-Lundmark K; Strauss BH
    Can J Cardiol; 2014 Nov; 30(11):1444-51. PubMed ID: 25249499
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Coordinated activation of VEGFR-1 and VEGFR-2 is a potent arteriogenic stimulus leading to enhancement of regional perfusion.
    Babiak A; Schumm AM; Wangler C; Loukas M; Wu J; Dombrowski S; Matuschek C; Kotzerke J; Dehio C; Waltenberger J
    Cardiovasc Res; 2004 Mar; 61(4):789-95. PubMed ID: 14985076
    [TBL] [Abstract][Full Text] [Related]  

  • 31. In mice with type 2 diabetes, a vascular endothelial growth factor (VEGF)-activating transcription factor modulates VEGF signaling and induces therapeutic angiogenesis after hindlimb ischemia.
    Li Y; Hazarika S; Xie D; Pippen AM; Kontos CD; Annex BH
    Diabetes; 2007 Mar; 56(3):656-65. PubMed ID: 17327433
    [TBL] [Abstract][Full Text] [Related]  

  • 32. HMGB1 and TLR4 mediate skeletal muscle recovery in a murine model of hindlimb ischemia.
    Sachdev U; Cui X; Tzeng E
    J Vasc Surg; 2013 Aug; 58(2):460-9. PubMed ID: 23414695
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Direct epicardial shock wave therapy improves ventricular function and induces angiogenesis in ischemic heart failure.
    Zimpfer D; Aharinejad S; Holfeld J; Thomas A; Dumfarth J; Rosenhek R; Czerny M; Schaden W; Gmeiner M; Wolner E; Grimm M
    J Thorac Cardiovasc Surg; 2009 Apr; 137(4):963-70. PubMed ID: 19327525
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Impaired angiogenesis after hindlimb ischemia in type 2 diabetes mellitus: differential regulation of vascular endothelial growth factor receptor 1 and soluble vascular endothelial growth factor receptor 1.
    Hazarika S; Dokun AO; Li Y; Popel AS; Kontos CD; Annex BH
    Circ Res; 2007 Oct; 101(9):948-56. PubMed ID: 17823371
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Vascular endothelial growth factor-C (VEGF-C/VEGF-2) promotes angiogenesis in the setting of tissue ischemia.
    Witzenbichler B; Asahara T; Murohara T; Silver M; Spyridopoulos I; Magner M; Principe N; Kearney M; Hu JS; Isner JM
    Am J Pathol; 1998 Aug; 153(2):381-94. PubMed ID: 9708799
    [TBL] [Abstract][Full Text] [Related]  

  • 36. The Role of Vascular Endothelial Growth Factor Receptor-1 Signaling in the Recovery from Ischemia.
    Amano H; Kato S; Ito Y; Eshima K; Ogawa F; Takahashi R; Sekiguchi K; Tamaki H; Sakagami H; Shibuya M; Majima M
    PLoS One; 2015; 10(7):e0131445. PubMed ID: 26133989
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Angiogenic properties of sustained release platelet-rich plasma: characterization in-vitro and in the ischemic hind limb of the mouse.
    Bir SC; Esaki J; Marui A; Yamahara K; Tsubota H; Ikeda T; Sakata R
    J Vasc Surg; 2009 Oct; 50(4):870-879.e2. PubMed ID: 19679427
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Low-intensity pulsed ultrasound induces angiogenesis and ameliorates left ventricular dysfunction in a porcine model of chronic myocardial ischemia.
    Hanawa K; Ito K; Aizawa K; Shindo T; Nishimiya K; Hasebe Y; Tuburaya R; Hasegawa H; Yasuda S; Kanai H; Shimokawa H
    PLoS One; 2014; 9(8):e104863. PubMed ID: 25111309
    [TBL] [Abstract][Full Text] [Related]  

  • 39. S100A1 deficiency impairs postischemic angiogenesis via compromised proangiogenic endothelial cell function and nitric oxide synthase regulation.
    Most P; Lerchenmüller C; Rengo G; Mahlmann A; Ritterhoff J; Rohde D; Goodman C; Busch CJ; Laube F; Heissenberg J; Pleger ST; Weiss N; Katus HA; Koch WJ; Peppel K
    Circ Res; 2013 Jan; 112(1):66-78. PubMed ID: 23048072
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Antiangiogenic effect of angiotensin II type 2 receptor in ischemia-induced angiogenesis in mice hindlimb.
    Silvestre JS; Tamarat R; Senbonmatsu T; Icchiki T; Ebrahimian T; Iglarz M; Besnard S; Duriez M; Inagami T; Lévy BI
    Circ Res; 2002 May; 90(10):1072-9. PubMed ID: 12039796
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.